Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation

BACKGROUND: Modified-release tacrolimus (TAC) is a new, once-daily oral formulation of the established immunosuppressive agent TAC. This study evaluated long-term patient adherence, as well as safety and efficacy, in stable patients after heart transplantation (HTx) who switched from a conventional...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Doesch, Andreas O, Mueller, Susanne, Akyol, Ceylan, Erbel, Christian, Frankenstein, Lutz, Ruhparwar, Arjang, Ehlermann, Philipp, Dengler, Thomas J, Katus, Hugo A
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3808207/
https://ncbi.nlm.nih.gov/pubmed/24174870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S52820
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados